• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Bone Biologics CEO Shares Update and Outlook With Stockholders

    BUSINESSWIRE

    Bone Bio to Participate in H.C. Wainwright Investment Conference

    BUSINESSWIRE

    Bone Biologics Patents Bone Regeneration Technology

    BUSINESSWIRE

    Bone Biologics Regains Nasdaq Listing Compliance

    BUSINESSWIRE

    Bone Biologics Appoints Robert E. Gagnon to Board of Directors

    BUSINESSWIRE

    Bone Biologics Announces 1-for-8 Reverse Stock Split

    BUSINESSWIRE

    Bone Biologics Engages Avania for NB1 Clinical Trial

    CONTRACT PHARMA

    Bone Biologics CEO Issues Letter to Stockholders

    BUSINESSWIRE

    Bone Biologics Announces Closing of $5,100,000 Underwritten Public Offering

    BUSINESSWIRE

    Bone Biologics announces ~$8M stock offering, reverse stock split

    SEEKINGALPHA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.